$ Value
$20K
Shares
918
Price
$22
Filed
Feb 11
Insider
Name
Soriano Maria Cecilia
Title
Group Pres., ITT & Pharma.
CIK
0002098784
Roles
Transaction Details
Transaction Date
2026-02-09
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
56,006
Footnotes
Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. | Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. | Total includes the automatic reinvestment of dividends.
Filing Info
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-02-09 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-02-09 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-02-09 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-02-09 |